OGEN
Oragenics Inc
NYSE MKT: OGEN · HEALTHCARE · BIOTECHNOLOGY
$0.60
-1.21% today
Updated 2026-04-29
Market cap
$2.62M
P/E ratio
—
P/S ratio
89.28x
EPS (TTM)
$-4.56
Dividend yield
—
52W range
$1 – $10
Volume
0.3M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.00
+230.96%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.84M
- Revenue declining -91.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $131521.00 | $37653.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-14.29M | $-20.66M | $-10.57M | $-9.84M | $-2.29M |
| EPS | — | — | — | — | $-4.56 |
| Free cash flow | $-15.36M | $-8.29M | $-8.60M | $-9.25B | $-2.84M |
| Profit margin | -10,863.96% | -54,858.14% | — | — | — |
Peer comparison
Smart narrative
Oragenics Inc trades at $0.60. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is Oragenics Inc's stock price?
Oragenics Inc (OGEN) trades at $0.60.
Is Oragenics Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Oragenics Inc (OGEN)?
The analyst target price is $2.00, representing +231.0% upside from the current price of $0.60.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio89.28x
ROE-243.90%
Beta1.21
50D MA$0.71
200D MA$0.99
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—